Literature DB >> 27449450

Trimodality Therapy for an Advanced Thymic Carcinoma With Both Aorta and Vena Cava Invasion.

Tohru Momozane1, Masayoshi Inoue2, Yasushi Shintani1, Soichiro Funaki1, Tomohiro Kawamura1, Masato Minami1, Yukitoshi Shirakawa3, Toru Kuratani3, Yoshiki Sawa3, Meinoshin Okumura1.   

Abstract

A case of locally advanced thymic carcinoma that was successfully resected with the great vessels after chemoradiation therapy is reported. A 57-year-old man with Masaoka stage III thymic carcinoma received two cycles of cisplatin/docetaxel and 60 Gy irradiation. The response was stable disease with 19% size reduction, and a radical resection with the ascending aorta and superior vena cava with the patient under circulatory arrest with the use of cardiopulmonary bypass was performed. The postoperative course was uneventful, and the patient has been free of disease for 28 months. Trimodality therapy with use of a cardiovascular surgical procedure might be a valuable option in locally advanced thymic carcinoma.
Copyright © 2016 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27449450     DOI: 10.1016/j.athoracsur.2016.01.014

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  3 in total

Review 1.  Surgical management of thymic epithelial tumors.

Authors:  Yasushi Shintani; Soichiro Funaki; Naoko Ose; Takashi Kanou; Eriko Fukui; Kenji Kimura; Masato Minami
Journal:  Surg Today       Date:  2020-07-10       Impact factor: 2.549

2.  KRAS mutation-positive mucinous adenocarcinoma originating in the thymus.

Authors:  Ichiro Sakanoue; Hiroshi Hamakawa; Daichi Fujimoto; Yukihiro Imai; Kazuhiro Minami; Keisuke Tomii; Yutaka Takahashi
Journal:  J Thorac Dis       Date:  2017-08       Impact factor: 2.895

3.  Salvage surgery for stage IVa thymic carcinoma combined with aortic arch resection - case report.

Authors:  Hiroyuki Yamato; Soichiro Funaki; Kazuo Shimamura; Keiwa Kin; Toru Kuratani; Yoshiki Sawa; Yasushi Shintani
Journal:  J Cardiothorac Surg       Date:  2020-10-07       Impact factor: 1.637

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.